Filing Flows › Cardio Diagnostics Holdings (CDIO) › Q3 2026 › vs Q2 2026
Cardio Diagnostics Holdings (CDIO) Q3 2026 vs Q2 2026 (quarter over quarter)
Cardio Diagnostics Holdings's revenue fell $2K (-33%) from $5K in Q2 2026 to $4K in Q3 2026.
Cardio Diagnostics Holdings, Q3 2026: revenue $4K (+26% year over year), net loss $1.7M, operating cash flow −$1.5M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $4K | $5K | −$2K | -33% |
| Net loss | $1.7M | $1.5M | $231K | +15% |
| Costs & expenses | $1.7M | $1.5M | $229K | +15% |
| Operating costs | $1.7M | $1.5M | $230K | +15% |
| Interest & other, net | $2K | $3K | −$1K | -35% |
| Research & development | $174K | $163K | $11K | +7% |
| Sales & marketing | $211K | $190K | $21K | +11% |
| General & admin | $1.3M | $1.1M | $198K | +17% |
| Other operating costs | $6K | $6K | $386 | +7% |
| Operating cash sources | $1.7M | $1.5M | $231K | +15% |
| Depreciation & amortization | $6K | $6K | $386 | +7% |
| Share-based compensation | $24K | $24K | −$14 | -0.1% |
| Working capital & other | $186K | $129K | $57K | +44% |
| Cash used in operations | $1.5M | $1.3M | $174K | +13% |
| Net loss absorbed | $1.7M | $1.5M | $231K | +15% |
Questions
How much did Cardio Diagnostics Holdings's revenue grow quarter over quarter in Q3 2026?
Cardio Diagnostics Holdings's revenue fell $2K (-33%) from $5K in Q2 2026 to $4K in Q3 2026.